Logo
  • About Us
    • Our Team
    • Advisory Board
  • Portfolio
  • Exeed
  • Strategy
    • Investment Criteria
    • Business Plan Submission
  • News
    • Epidarex News
    • Epidarex Portfolio News
  • Contact Us
  • About Us
    • Our Team
    • Advisory Board
  • Portfolio
  • Exeed
  • Strategy
    • Investment Criteria
    • Business Plan Submission
  • News
    • Epidarex News
    • Epidarex Portfolio News
  • Contact Us

May 2018

09 May
15

IGEM Therapeutics Announces UK Government Funding to Develop a Novel IgE Antibody Targeting Solid Tumours

In All, Portfolio

£1.45 million grant from Innovate UK Biomedical Catalyst Funds enable IGEM to progress second product candidate towards the clinic London, 9 May 2018 – IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, today announced the award of a…

Categories
  • Epidarex News
  • Epidarex Portfolio News
Archives
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • December 2014
  • November 2014
  • October 2014
  • May 2014
  • February 2014
  • August 2013
  • January 2013
© Copyright Epidarex 2018. All rights reserved.
Privacy Policy  |  Terms & Conditions